Heparin Calcium Wockhardt Uk

Heparin Calcium Wockhardt UK is an injectable anticoagulant containing the active ingredient heparin calcium. It is supplied in a sterile solution for intravenous or subcutaneous administration and is marketed in the European Union. The product is prescription‑only and classified as an antithrombotic agent that works by enhancing antithrombin III activity to reduce clot formation.

Heparin Calcium Wockhardt UK is indicated for several antithrombotic purposes in clinical practice.

- Prevention and treatment of venous thromboembolism, including deep vein thrombosis and pulmonary embolism. - Prophylaxis of deep vein thrombosis in patients undergoing major surgery or orthopedic procedures. - Management of acute coronary syndromes such as unstable angina or myocardial infarction. - Bridging anticoagulation for patients transitioning between oral anticoagulants. - Use during extracorporeal circulation, such as cardiopulmonary bypass, to maintain anticoagulation.

Side effects of heparin calcium may vary in frequency and severity.

Common: - Minor bleeding at injection sites or from mucous membranes. - Small bruising or hematoma formation around the administration area. - Transient elevation of liver enzymes detected in laboratory tests. - Mild thrombocytopenia that resolves without intervention.

Serious: - Major hemorrhage, including intracranial or gastrointestinal bleeding. - Heparin‑induced thrombocytopenia (HIT) with a risk of new clot formation. - Allergic reactions ranging from rash to anaphylaxis. - Spinal or epidural hematoma when used near the central nervous system. - Severe elevation of liver transaminases indicating hepatic injury.

When prescribing Heparin Calcium Wockhardt UK, clinicians should consider several safety factors.

- Assess patient history for bleeding disorders, recent surgery, or trauma. - Monitor platelet counts regularly to detect heparin‑induced thrombocytopenia. - Adjust dosing in patients with renal or hepatic impairment as needed. - Use caution in pregnant women; although category B, benefits must outweigh potential risks. - Avoid concurrent use with other anticoagulants or antiplatelet agents unless medically justified. - Conduct baseline and periodic coagulation tests (e.g., aPTT) to guide therapy.

Heparin calcium can interact with various medications, influencing its anticoagulant effect.

Avoid: - Concurrent use of other anticoagulants such as warfarin, direct oral anticoagulants, or low‑molecular‑weight heparins without specialist supervision. - Combination with potent antiplatelet drugs (e.g., clopidogrel, aspirin) that markedly increase bleeding risk. - Administration with fibrinolytic agents (e.g., alteplase) due to additive hemorrhagic potential.

Use with caution: - Non‑steroidal anti‑inflammatory drugs (NSAIDs) that may impair platelet function. - Certain antibiotics (e.g., quinolones) that can enhance anticoagulant activity. - Herbal supplements such as ginkgo biloba or garlic that possess mild antithrombotic properties.